Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: Which patients benefit?

European Urology

Volumn 64, Issue 3, 2013, Pages 355-357

  Niegisch, Günter ^a   Lorch, Anja ^a   Droller, Michael J ^b   Lavery, Hugh J ^b   Stensland, Kristian D ^b   Albers, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE BLADDER CANCER; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK BENEFIT ANALYSIS; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; EVIDENCE-BASED MEDICINE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84881158258     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.06.002     Document Type: Letter

References (14)

1. S. Madersbacher, W. Hochreiter, and F. Burkhard Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690 696
2. R.E. Hautmann, J.E. Gschwend, R.C. de Petriconi, M. Kron, and B.G. Volkmer Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era J Urol 176 2006 486 492 discussion 491-2
3. R.E. Hautmann, R.C. de Petriconi, C. Pfeiffer, and B.G. Volkmer Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: Long-term results in 1100 patients Eur Urol 61 2012 1039 1047
4. S. Tritschler, C. Mosler, D. Tilki, A. Buchner, C. Stief, and A. Graser Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer Urology 79 2012 1317 1321
5. M.L. Paik, M.J. Scolieri, S.L. Brown, J.P. Spirnak, and M.I. Resnick Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy J Urol 163 2000 1693 1696
6. A. Rajesh, H.K. Sokhi, R. Fung, K.A. Mulcahy, and M.J. Bankart Bladder cancer: Evaluation of staging accuracy using dynamic MRI Clin Radiol 66 2011 1140 1145
7. G. Griffiths, R. Hall, R. Sylvester, D. Raghavan, and M.K. Parmar International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171 2177
8. A. Sherif, E. Rintala, and O. Mestad Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2 Scand J Urol Nephrol 36 2002 419 425
9. H.B. Grossman, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
10. P.U. Malmstrom, E. Rintala, R. Wahlqvist, P. Hellstrom, S. Hellsten, and E. Hannisdal Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group J Urol 155 1996 1903 1906
11. Inernational Collaboration of Trialists Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial Lancet 354 1999 533 540
12. O. Yeshchina, G.M. Badalato, and M.S. Wosnitzer Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder Urology 79 2012 384 390
13. D. Canter, R. Viterbo, and A. Kutikov Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy Urology 77 2011 160 165
14. E. Scosyrev, E.M. Messing, and E. van Wijngaarden Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder Cancer 118 2012 72 81